Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy

NCT02528045 — Completed, 16 participants, Kyorin University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Efficacy of Surgical Treatment of Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy

RegistryNCT02528045
StatusCompleted
Study typeObservational
Enrollment16 (Actual)
SponsorKyorin University (Other)
ConditionsMacular Hole Retinal Detachment, Myopic Traction Maculopathy
InterventionsVitrectomy with scleral shortening (Procedure)
Datesstart 2012-06-01, primary completion 2014-07-01, completion 2015-06-01, first posted 2015-08-19, last updated 2015-08-19
Locations1 site in Japan

Related Papers Related Patents Related Grants Related Experts
All trials for Macular Hole Retinal Detachment All trials for Myopic Traction Maculopathy All trials of Vitrectomy with scleral shortening

-Summary

The medical records of 16 eyes of 16 patients with macular hole retinal detachment or myopic traction maculopathy who received viterctomy including internal limiting membrane peeling and scleral shorting surgery were reviewed. Best-corrected visual acuity, axial length, retinal reattachment and macular hole closure, the shape of staphyloma determined by optical coherence tomography and 3-dimensional magnetic resonance imaging were assessed.

Expand all sections  ·  Collapse all

+Arms and interventions

  • Vitrectomy with scleral shortening (Procedure)

+Outcome measures

Primary outcomes

  • Visual acuity before and after surgery [6 months]: Comparison with logarithm of Minimum Angle of Resolution (logMAR) vision

Secondary outcomes

  • Retinal reattachment [6 months]: Retinal reattachment or resolution of myopic traction maculopathy

+Eligibility

Sex: All, ages: 20 Years to 90 Years

Inclusion Criteria:

* The inclusion criteria were patients who had highly myopic eyes with macular hole retinal detachment to myopic traction maculopathy

Exclusion Criteria:

* The patients with follow-up less than 6 months

+Locations (1)

FacilityCityCountryStatus
Makoto InoueMitaka, TokyoJapan

+Investigators